Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Comparison of soluble Fms-like tyrosine kinase-1 (sFlt-1) (A), free vascular endothelial growth factor (VEGF) (B), free placental growth factor (PlGF) (C), and total VEGF (D) levels during the follow-up period after AMI in patients treated with atorvastatin (n = 25) and placebo (n = 25). *p < 0.05 vs. respective levels in the acute phase of myocardial infarction. {dagger}p < 0.05 vs. healthy control subjects.